Patents by Inventor David Entenberg

David Entenberg has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12174190
    Abstract: A combination of markers (TMEM, MenaCalc, and MenalNV) for hematogenous metastatic cancer and their use for diagnosis, prognosis and predictive performance are disclosed.
    Type: Grant
    Filed: December 18, 2018
    Date of Patent: December 24, 2024
    Assignee: Albert Einstein College of Medicine
    Inventors: John S. Condeelis, Maja H. Oktay, Joan Jones, David Entenberg
  • Patent number: 12089959
    Abstract: Methods and apparatus are provided for high resolution intravital imaging and for chronic optical imaging of tissues such as lung.
    Type: Grant
    Filed: June 21, 2023
    Date of Patent: September 17, 2024
    Assignee: Albert Einstein College of Medicine
    Inventors: David Entenberg, John S. Condeelis, Sonia E. Voiculescu
  • Publication number: 20240000391
    Abstract: Methods and apparatus are provided for high resolution intravital imaging and for chronic optical imaging of tissues such as lung.
    Type: Application
    Filed: June 21, 2023
    Publication date: January 4, 2024
    Inventors: David Entenberg, John S. Condeelis, Sonia E. Voiculescu
  • Patent number: 11712205
    Abstract: Methods and apparatus are provided for high resolution intravital imaging and for chronic optical imaging of tissues such as lung.
    Type: Grant
    Filed: August 1, 2018
    Date of Patent: August 1, 2023
    Assignee: Albert Einstein College of Medicine
    Inventors: David Entenberg, John S. Condeelis, Sonia E. Voiculescu
  • Publication number: 20200393467
    Abstract: A combination of markers (TMEM, MenaCalc, and MenalNV) for hematogenous metastatic cancer and their use for diagnosis, prognosis and predictive performance are disclosed.
    Type: Application
    Filed: December 18, 2018
    Publication date: December 17, 2020
    Inventors: John S. Condeelis, Maja H. Oktay, Joan Jones, David Entenberg
  • Publication number: 20200352516
    Abstract: Methods and apparatus are provided for high resolution intravital imaging and for chronic optical imaging of tissues such as lung.
    Type: Application
    Filed: August 1, 2018
    Publication date: November 12, 2020
    Inventors: David Entenberg, John S. Condeelis, Sonia E. Voiculescu
  • Patent number: 10117990
    Abstract: A microfluidic intravital window includes an intravital imaging window adapted for implantation adjacent target tissue of a live animal, and a microfluidic fluid source and delivery system physically integrated into the window for controlled delivery of fluids to target tissue via the window. The microfluidic fluid source and delivery system is self-contained and completely located within the intravital imaging window, and includes at least one preloaded fluid reservoir, at least one fluid port in fluidic communication with both the at least one preloaded fluid reservoir and the target tissue, and at least one light activated fluid flow control device situated between the at least one preloaded fluid reservoir and at least one fluid port, to facilitate simultaneous in vivo viewing and remotely controlled fluid delivery to the target tissue.
    Type: Grant
    Filed: December 7, 2016
    Date of Patent: November 6, 2018
    Assignees: The Research Foundation for the State University of New York, Albert Einstein College of Medicine, Inc.
    Inventors: James Castracane, Logan Butt, David Entenberg, Lauren Sfakis, John Condeelis
  • Publication number: 20180154073
    Abstract: A microfluidic intravital window includes an intravital imaging window adapted for implantation adjacent target tissue of a live animal, and a microfluidic fluid source and delivery system physically integrated into the window for controlled delivery of fluids to target tissue via the window. The microfluidic fluid source and delivery system is self-contained and completely located within the intravital imaging window, and includes at least one preloaded fluid reservoir, at least one fluid port in fluidic communication with both the at least one preloaded fluid reservoir and the target tissue, and at least one light activated fluid flow control device situated between the at least one preloaded fluid reservoir and at least one fluid port, to facilitate simultaneous in vivo viewing and remotely controlled fluid delivery to the target tissue.
    Type: Application
    Filed: December 7, 2016
    Publication date: June 7, 2018
    Applicants: THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK, ALBERT EINSTEIN COLLEGE OF MEDICINE, INC.
    Inventors: James CASTRACANE, Logan BUTT, David Entenberg, Lauren Sfakis, John CONDEELIS